JACK E. STOVER - 18 Aug 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Issuer symbol
ONTX
Transactions as of
18 Aug 2022
Transactions value $
$0
Form type
4
Filing time
19 Aug 2022, 17:10:11 UTC
Previous filing
23 Aug 2022
Next filing
14 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +66.5K $0.00 66.5K 18 Aug 2022 Common Stock 66.5K $1.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest 100% on the first anniversary of the grant date.